NeuroPace (NPCE) Asset Writedowns and Impairment (2020 - 2026)
NeuroPace's quarterly Asset Writedowns and Impairment came in at $76000.0 in Q1 2026, up 72.73% year-on-year from $44000.0 in Q1 2025, and up 26.67% quarter-over-quarter from $60000.0 in Q4 2025.
NeuroPace has reported Asset Writedowns and Impairment for 7 years, with the latest figure at $76000.0 in Q1 2026.
- For the quarter ending Q1 2026, Asset Writedowns and Impairment rose 72.73% year-over-year to $76000.0; the trailing twelve-month figure through Mar 2026 stood at $232000.0 (down 6.45% YoY), and the FY2025 full-year result was $200000.0, down 20.32% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $76000.0, up from $60000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $107000.0 in Q3 2024, with the low at -$4000.0 in Q4 2022.
- Average Asset Writedowns and Impairment over 5 years is $54294.1, with a median of $49000.0 recorded in 2025.
- Year-over-year, Asset Writedowns and Impairment sank 107.02% in 2022 and surged 1700.0% in 2023.
- Tracing NPCE's Asset Writedowns and Impairment over 5 years: stood at -$4000.0 in 2022, then surged by 1700.0% to $64000.0 in 2023, then dropped by 14.06% to $55000.0 in 2024, then gained by 9.09% to $60000.0 in 2025, then gained by 26.67% to $76000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $76000.0 (Q1 2026), $60000.0 (Q4 2025), and $47000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76,000.00 |
| Mar 31, 2026 | 76,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | 107,000.00 |
| Sep 30, 2024 | 107,000.00 |
| Jun 30, 2024 | 42,000.00 |
| Jun 30, 2024 | 42,000.00 |
| Mar 31, 2024 | 47,000.00 |
| Mar 31, 2024 | 47,000.00 |
| Dec 31, 2023 | 64,000.00 |
| Dec 31, 2023 | 64,000.00 |
| Sep 30, 2023 | 44,000.00 |
| Sep 30, 2023 | 44,000.00 |
| Jun 30, 2023 | 54,000.00 |
| Jun 30, 2023 | 54,000.00 |
| Mar 31, 2023 | 34,000.00 |
| Mar 31, 2023 | 34,000.00 |
| Dec 31, 2022 | -4,000.00 |
| Dec 31, 2022 | -4,000.00 |
| Sep 30, 2022 | 35,000.00 |
| Sep 30, 2022 | 35,000.00 |
| Jun 30, 2022 | 87,000.00 |
| Jun 30, 2022 | 87,000.00 |
| Mar 31, 2022 | 82,000.00 |
| Mar 31, 2022 | 82,000.00 |
| Dec 31, 2021 | 57,000.00 |
| Dec 31, 2021 | 57,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Jun 30, 2021 | 138,000.00 |
| Jun 30, 2021 | 138,000.00 |
| Mar 31, 2021 | 24,000.00 |
| Mar 31, 2021 | 24,000.00 |
| Dec 31, 2020 | -226,000.00 |
| Dec 31, 2020 | -226,000.00 |
| Sep 30, 2020 | 295,000.00 |
| Sep 30, 2020 | 295,000.00 |
| Jun 30, 2020 | 154,000.00 |
| Jun 30, 2020 | 154,000.00 |
| Mar 31, 2020 | 97,000.00 |
| Mar 31, 2020 | 97,000.00 |